Major Shift in Smoking Habits Among New Zealand Teenagers

Industry Insight by 2FIRSTS.ai
Dec.12.2023
Major Shift in Smoking Habits Among New Zealand Teenagers
New Zealand teens' e-cigarette use declines significantly, marking a crucial turning point in youth smoking habits, according to recent survey.

According to a report by the New Zealand technology newspaper Tech Times on December 10th, an investigation conducted by Action on Smoking and Health (ASH), a New Zealand anti-smoking organization, has observed a significant shift in smoking habits among New Zealand teenagers. The survey findings indicate a notable decline in the frequency of e-cigarette use among students.

 

A survey has revealed that the habit of regularly using e-cigarettes has seen a significant decrease among 10 students, dropping from 18.2% in 2022 to 16.4% in 2023.

 

This decline marks a pivotal turning point, reflecting a departure from the previous upward trend in adolescent e-cigarette usage. The percentage of teenagers who vape e-cigarettes daily has now stabilized at 10%, while the number of individuals experimenting with e-cigarette usage has dropped from 40.1% to 37.5% during the same period.

 

The director of the anti-smoking organization, Ben Youdan, expressed encouragement regarding this result, attributing the positive trend to the control measures implemented in recent years. However, he emphasized the need for continued efforts, acknowledging that although there has been evident progress, reducing the prevalence of e-cigarette usage among adolescents remains crucial.

 

According to You Dan, "Despite the fact that the rate of teenagers using e-cigarettes is still higher than expected, it is encouraging to see fewer young people getting involved in using e-cigarettes and experimenting with tobacco products.

 

Anti-smoking organizations also expressed satisfaction with the declining trend in smoking. Only 1.2% of respondents reported daily smoking, while the number of non-smokers has skyrocketed to 87.8%, indicating a clear rejection of tobacco products among New Zealand teenagers.

 

The investigation also highlighted some noteworthy trends within the Māori community. The proportion of Māori who have never smoked has seen an increase, currently standing at 77.7%, with a growth rate of 4%. However, concerning is the fact that Māori girls are 2.5 times more likely to use e-cigarettes compared to their peers.

 

Fay Selby-Law, the director of the Anti-Smoking Action Group and the head of Maori SUDI prevention services, emphasized the importance of intensifying efforts to prevent Maori youth from smoking.

 

Selby-Law argues, "While e-cigarettes have assisted many adults in quitting smoking, the pressing issue lies in keeping these devices out of the hands of young individuals.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s retail licensing system took effect on Feb. 2, 2026, charging annual fees per point of sale and enforced by the Health Service Executive (HSE). British American Tobacco’s local unit, BAT Ireland, said excluding nicotine pouches could leave a regulatory gap.
Feb.04 by 2FIRSTS.ai
Canadian Border Officers Seize Contraband Worth CAD 4.5 Million at Point Edward Crossing
Canadian Border Officers Seize Contraband Worth CAD 4.5 Million at Point Edward Crossing
The Canada Border Services Agency said border officers at the Point Edward port of entry in Sarnia, Ontario, seized more than CAD 4.5 million worth of illegal tobacco and nicotine vapes over a seven-day period. The agency said the contraband was entering Canada from the United States and described the seizure as part of ongoing efforts to prevent illegal products from entering the country and disrupt organized crime.
Mar.26 by 2FIRSTS.ai
Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market
Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market
According to a LinkedIn post published by Sesh CMO Josh Metz on February 25, 2026, Sesh Products has introduced a 200-pouch nicotine pouch refill bag sold with a reusable metal can. In a U.S. MO market dominated by 20-pouch plastic cans, the product offers a larger retail unit size. The company lists a standard price of USD 49.99, with a uniform 15% discount currently applied, bringing the price to USD 42.49.
Innovation
Feb.25
FDA Issues Draft PMTA Guidance for Flavored E-Cigarettes, Maintaining Higher Evidence Bar for Fruit and Sweet Flavors
FDA Issues Draft PMTA Guidance for Flavored E-Cigarettes, Maintaining Higher Evidence Bar for Fruit and Sweet Flavors
The U.S. Food and Drug Administration (FDA) on March 9 released a draft guidance outlining its current thinking on premarket tobacco product applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS). The document reiterates that fruit, candy, dessert, and other sweet-flavored e-cigarettes present a “significant public health risk” to youth and therefore face a higher evidentiary burden if manufacturers seek marketing authorization.
Mar.10 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24